CLEVIPREX (clevidipine injectable emulsion)
Lack of Assurance of Sterility
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Failed Stability Specifications: Out of specification stability result for the protein concentration profile.
Cause type: Stability / shelf life
The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.
Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01
Compare with the code on your package — it is the most precise check available.
From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.
| Product | Strength | Form & route | Labeler | Type |
|---|---|---|---|---|
| Revcovi elapegademase-lvlr NDC 10122-0502 |
ELAPEGADEMASE 1.6 mg/mL | Injection Intramuscular |
Chiesi USA, Inc. | Rx |
Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Failed Dissolution Specifications: Out of specification result for dissolution.
Failed Dissolution Specifications: Out of specification result for dissolution.
Failed Stability Specifications
Failed Stability Specifications
Failed Stability Specifications
Failed Stability Specifications
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.